5-aminolevulinic acid + sodium ferrous citrate for cardioprotection in adults undergoing cardiac surgery

Phase 2, randomised trial of 5-aminolevulinic acid and sodium ferrous citrate in low cardiac output syndrome (LCOS) and Myocardial injury (2 arms), sponsored by University of Oxford. Primary endpoint: Incidence of low cardiac output state at 6 hours after cessation of cardiopulmonary bypass. Status: unknown.